Asset Details
Do you wish to reserve the book?
Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli
Do you wish to request the book?
Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli
2020
Overview
Escherichia coli
is an important model organism in microbiology and a prominent member of the human microbiota
1
. Environmental isolates readily colonize the gastrointestinal tract of humans and other animals, and they can serve diverse probiotic, commensal and pathogenic roles in the host
2
–
4
. Although certain strains have been associated with the severity of inflammatory bowel disease (IBD)
2
,
5
, the diverse immunomodulatory phenotypes remain largely unknown at the molecular level. Here, we decode a previously unknown
E. coli
metabolic pathway that produces a family of hybrid pterin–phenylpyruvate conjugates, which we named the colipterins. The metabolites are upregulated by subinhibitory levels of the antifolate sulfamethoxazole, which is used to treat infections including in patients with IBD
6
,
7
. The genes
folX/M
and
aspC/tyrB
involved in monapterin biosynthesis
8
–
10
and aromatic amino acid transamination,
11
respectively, were required to initiate the colipterin pathway. We show that the colipterins are antioxidants, harbour diverse immunological activities in primary human tissues, activate anti-inflammatory interleukin-10 and improve colitis symptoms in a colitis mouse model. Our study defines an antifolate stress response in
E. coli
and links its associated metabolites to a major immunological marker of IBD.
Subinhibitory levels of sulfamethoxazole, an antibiotic used to treat
Escherichia coli
infections, trigger a previously undescribed metabolic pathway in
E. coli
that comprises a family of hybrid pterin–phenylpyruvate conjugates called colipterins. These metabolites are antioxidants, have immunomodulatory properties and improve colitis in a murine model.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 13/31
/ 38/77
/ 64/60
/ Animals
/ Antioxidants - administration & dosage
/ Biomedical and Life Sciences
/ Colitis
/ E coli
/ Escherichia coli - metabolism
/ Escherichia coli - physiology
/ Escherichia coli Proteins - genetics
/ Escherichia coli Proteins - metabolism
/ Humans
/ Letter
/ Metabolic Networks and Pathways
/ Mice
/ Pteridines - administration & dosage
/ Sulfamethoxazole - administration & dosage
/ Sulfamethoxazole - metabolism
/ Virology
